Bioventus Inc.BVSNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank17
3Y CAGR+40.8%
5Y CAGR-17.3%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+40.8%/yr
vs -45.0%/yr prior
5Y CAGR
-17.3%/yr
Recent acceleration
Acceleration
+85.8pp
Accelerating
Percentile
P17
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.87 | -27.1% |
| 2024 | 1.20 | +85.8% |
| 2023 | 0.64 | +106.0% |
| 2022 | 0.31 | -79.5% |
| 2021 | 1.53 | -32.2% |
| 2020 | 2.25 | -29.7% |
| 2019 | 3.21 | -6.2% |
| 2018 | 3.42 | -8.5% |
| 2017 | 3.74 | -6.0% |
| 2016 | 3.98 | - |